$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer 원문보기

The Korean journal of internal medicine : KJIM, v.23 no.1, 2008년, pp.37 - 41  

Jung, Jong Yul (Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.) ,  Rha, Sun Young (Cancer Metastasis Research Center, Yonsei University College of Medicine, Seoul, Korea.) ,  Ahn, Joong Bae (Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.) ,  Yang, Woo Ick (Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.) ,  Noh, Sung Hoon (Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.) ,  Chung, Hyun Cheol (Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.) ,  Jeung, Hei-Cheul (Cancer Metastasis Research Center, Yonsei University College of Medicine, Seoul, Korea.)

Abstract AI-Helper 아이콘AI-Helper

S-1, a novel oral fluoropyrimidine, is an effective therapeutic agent for gastric cancer. Herein, we report a case with locally advanced gastric cancer that achieved a curative resection after S-1 monotherapy as neoadjuvant treatment. A 68-year-old man was diagnosed with gastric cancer and massive l...

주제어

참고문헌 (15)

  1. 1 Roder JD Böttcher K Siewert JR Busch R Hermanek P Meyer HJ Prognostic factors in gastric carcinoma: results of the German Gastric Carcinoma Study 1992 Cancer 1993 72 2089 2097 8374867 

  2. 2 Rougier P Lasser P Ducreux M Mahjoubi M Bognel C Elias D Preoperative chemotherapy of locally advanced gastric cancer Ann Oncol 1994 5 Suppl 3 59 68 

  3. 3 Wilke H Preusser P Fink U Gunzer U Meyer HJ Meyer J Siewert JR Achterrath W Lenaz L Knipp H Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin J Clin Oncol 1989 7 1318 1326 2769330 

  4. 4 Forshaw MJ Gossage JA Chrystal K Cheong K Atkinson S Botha A Harper PG Mason RC Neoadjuvant chemotherapy for locally advanced carcinoma of the lower oesophagus and oesophago-gastric junction Eur J Surg Oncol 2006 32 1114 1118 16621430 

  5. 5 Cascinu S Scartozzi M Labianca R Catalano V Siliva RR Barni S Zaniboni A D'Angelo A Salvagni S Martignoni G Beretta GD Graziano E Berardi R Franciosi V High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, gluathione and filgrastim in patients with locally advanced unresectable gastric cancer Br J Cancer 2004 90 1521 1525 15083179 

  6. 6 Schuhmacher CP Fink U Becker K Busch R Dittler HJ Mueller J Siewert JR Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum: closing results after 5 years of follow-up Cancer 2001 91 918 927 11251943 

  7. 7 Shirasaka T Shimamato Y Ohshimo H Yamaguchi M Kato T Yonekura K Fukushima M Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators Anticancer Drugs 1996 7 548 557 8862723 

  8. 8 Sakata Y Ohtsu A Hirokoshi N Sugimachi K Mitachi Y Taguchi T Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients Eur J Cancer 1998 34 1715 1720 9893658 

  9. 9 Sugimachi K Maehara Y Horikoshi N Shimada Y Sakata Y Mitachi Y Taguchi T An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers Oncology 1999 57 202 210 10545788 

  10. 10 Kochi M Fujii M Kanamori N Kaiga T Takahashi T Kobayashi M Takayama T Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer J Cancer Res Clin Oncol 2006 132 781 785 16804723 

  11. 11 Satoh S Hasegawa S Ozaki N Okabe H Watanabe G Nagayama S Fukushima M Takabayashi A Sakai Y Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination Gastric cancer 2006 9 129 135 16767369 

  12. 12 Iwahashi M Nakamori M Tani M Yamaue H Sakaguchi S Nakamura M Ueda K Ichiro M Nishino E Tanimura H Complete response of highly advanced gastric cancer with peritoneal dissemination after new combined chemotherapy of S-1 and low-dose cisplatin: report of a case Oncology 2001 61 16 22 11474243 

  13. 13 Yamamoto Y Kino Y Ohara K Onuma S Asai K Kobayashi T Kono T Kasai S A case report of advanced cardiac cancer showing a complete response to TS-1 as neoadjuvant chemotherapy Gan To Kagaku Ryoho 2004 31 579 583 15114703 

  14. 14 Becker K Fumagalli U Mueller JD Fink U Siewert JR Hofler H Neoadjuvant chemotherapy for patients with locally advanced gastric carcinoma: effect on tumor cell microinvolvement of regional lymph nodes Cancer 1999 85 1484 1489 10193937 

  15. 15 Kawai H Ohtsu A Boku N Hamamoto Y Nagashima F Muto M Sano Y Mera K Yano T Doi T Yoshida S Efficacy and safety profile of S-1 in patients with metastatic gastric cancer in clinical practice: results from a postmarketing survey Gastric Cancer 2003 6 Suppl 1 19 23 12775015 

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로